# The Autism Biomarkers Consortium for Clinical Trials: Confirmation Study

> **NCT05294705** · — · COMPLETED · sponsor: **Yale University** · enrollment: 565 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05294705
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-11
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 565 (ACTUAL)
- **Last updated:** 2025-09-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05294705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05294705, "The Autism Biomarkers Consortium for Clinical Trials: Confirmation Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05294705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*